BrightGene Bio-Medical Technology Co., Ltd. 688166.SS Stock
BrightGene Bio-Medical Technology Co., Ltd. Price Chart
BrightGene Bio-Medical Technology Co., Ltd. 688166.SS Financial and Trading Overview
Contents
- BrightGene Bio-Medical Technology Co., Ltd. Price Chart
- BrightGene Bio-Medical Technology Co., Ltd. 688166.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of BrightGene Bio-Medical Technology Co., Ltd.
- Q&A For BrightGene Bio-Medical Technology Co., Ltd. Stock
| BrightGene Bio-Medical Technology Co., Ltd. stock price | 26.76 CNY |
| Previous Close | 22.72 CNY |
| Open | 22.51 CNY |
| Bid | 22.6 CNY x N/A |
| Ask | 22.63 CNY x N/A |
| Day's Range | 22.51 - 22.88 CNY |
| 52 Week Range | 17.1 - 26.16 CNY |
| Volume | 1.99M CNY |
| Avg. Volume | 2.91M CNY |
| Market Cap | 9.55B CNY |
| Beta (5Y Monthly) | 0.369936 |
| PE Ratio (TTM) | 37.666664 |
| EPS (TTM) | 0.55 CNY |
| Forward Dividend & Yield | 0.11 (0.52%) |
| Ex-Dividend Date | June 15, 2023 |
| 1y Target Est | N/A |
688166.SS Valuation Measures
| Enterprise Value | 10.6B CNY |
| Trailing P/E | 37.666664 |
| Forward P/E | 26.904762 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.890723 |
| Price/Book (mrq) | 4.14147 |
| Enterprise Value/Revenue | 9.867 |
| Enterprise Value/EBITDA | 37.509 |
Trading Information
BrightGene Bio-Medical Technology Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.369936 |
| 52-Week Change | -2.36% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 26.16 CNY |
| 52 Week Low | 17.1 CNY |
| 50-Day Moving Average | 22.77 CNY |
| 200-Day Moving Average | 22.19 CNY |
688166.SS Share Statistics
| Avg. Volume (3 month) | 2.91M CNY |
| Avg. Daily Volume (10-Days) | 3.17M CNY |
| Shares Outstanding | 422.46M |
| Float | 255.57M |
| Short Ratio | N/A |
| % Held by Insiders | 54.33% |
| % Held by Institutions | 13.14% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.114 |
| Trailing Annual Dividend Yield | 0.50% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 23.24% |
| Operating Margin (ttm) | 22.55% |
| Gross Margin | 60.34% |
| EBITDA Margin | 26.30% |
Management Effectiveness
| Return on Assets (ttm) | 3.60% |
| Return on Equity (ttm) | 10.33% |
Income Statement
| Revenue (ttm) | 1.07B CNY |
| Revenue Per Share (ttm) | 2.58 CNY |
| Quarterly Revenue Growth (yoy) | 22.80% |
| Gross Profit (ttm) | 626.38M CNY |
| EBITDA | 282.5M CNY |
| Net Income Avi to Common (ttm) | 249.64M CNY |
| Diluted EPS (ttm) | 0.6 |
| Quarterly Earnings Growth (yoy) | 16.50% |
Balance Sheet
| Total Cash (mrq) | 1.12B CNY |
| Total Cash Per Share (mrq) | 2.65 CNY |
| Total Debt (mrq) | 2.05B CNY |
| Total Debt/Equity (mrq) | 86.66 CNY |
| Current Ratio (mrq) | 2.167 |
| Book Value Per Share (mrq) | 5.457 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 365.97M CNY |
| Levered Free Cash Flow (ttm) | -214920384 CNY |
Profile of BrightGene Bio-Medical Technology Co., Ltd.
| Country | China |
| State | N/A |
| City | Suzhou |
| Address | Building C25-28 |
| ZIP | 215123 |
| Phone | 86 512 6262 0988 |
| Website | https://www.bright-gene.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1128 |
BrightGene Bio-Medical Technology Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of medicines, and generic APIs and FDFs in China. Its product pipeline includes immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, and novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis. The company also develops Eribulin, Trabectedin, Fondaparinux, Caspofungin, and non-biological molecules; macromolecules, such as Ferumoxytol and Ferric pyrophosphate citrate; and ADC cytotoxic payloads comprising Maytansinoids, Auristatins, and Calicheamicin. It offers cardiovascular, antibacterial, ADC, oncology, antifungal, iron supplement, anti-HBV, veterinary, and immuno products. The company was founded in 2001 and is based in Suzhou, China.
Q&A For BrightGene Bio-Medical Technology Co., Ltd. Stock
What is a current 688166.SS stock price?
BrightGene Bio-Medical Technology Co., Ltd. 688166.SS stock price today per share is 26.76 CNY.
How to purchase BrightGene Bio-Medical Technology Co., Ltd. stock?
You can buy 688166.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BrightGene Bio-Medical Technology Co., Ltd.?
The stock symbol or ticker of BrightGene Bio-Medical Technology Co., Ltd. is 688166.SS.
Which industry does the BrightGene Bio-Medical Technology Co., Ltd. company belong to?
The BrightGene Bio-Medical Technology Co., Ltd. industry is Biotechnology.
How many shares does BrightGene Bio-Medical Technology Co., Ltd. have in circulation?
The max supply of BrightGene Bio-Medical Technology Co., Ltd. shares is 422.47M.
What is BrightGene Bio-Medical Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
BrightGene Bio-Medical Technology Co., Ltd. PE Ratio is 48.65454500 now.
What was BrightGene Bio-Medical Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
BrightGene Bio-Medical Technology Co., Ltd. EPS is 0.55 CNY over the trailing 12 months.
Which sector does the BrightGene Bio-Medical Technology Co., Ltd. company belong to?
The BrightGene Bio-Medical Technology Co., Ltd. sector is Healthcare.